By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company 4basebio PLC

4basebio PLC (4BB.L)

LSE Currency in GBP
£995.50
+£5.50
+0.56%
Last Update: 17 Jul 2025, 11:28
£154.02M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£940.00 - £1.55K
52 Week Range

4BB.L Stock Price Chart

Explore 4basebio PLC interactive price chart. Choose custom timeframes to analyze 4BB.L price movements and trends.

There is nothing to show.

4BB.L Company Profile

Discover essential business fundamentals and corporate details for 4basebio PLC (4BB.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

17 Feb 2021

Employees

101.00

CEO

Heikki Lanckriet

Description

4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.

4BB.L Financial Timeline

Browse a chronological timeline of 4basebio PLC corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 May 2026

Upcoming earnings on 23 Sept 2025

Earnings released on 27 May 2025

EPS came in at -£0.52, while revenue for the quarter reached £605.00K, missing expectations by -48.38%.

Earnings released on 27 Sept 2024

EPS came in at -£0.45, while revenue for the quarter reached £328.00K.

Earnings released on 5 Jun 2024

EPS came in at -£0.33, while revenue for the quarter reached £268.00K, missing expectations by -86.60%.

Earnings released on 21 Sept 2023

EPS came in at -£0.29 falling short of the estimated -£0.28 by -3.06%, while revenue for the quarter reached £238.00K, meeting expectations.

Earnings released on 11 May 2023

EPS came in at -£0.22, while revenue for the quarter reached £116.00K.

Earnings released on 30 Sept 2022

EPS came in at -£0.20, while revenue for the quarter reached £152.00K.

Earnings released on 31 Dec 2021

EPS came in at -£0.13, while revenue for the quarter reached £159.00K.

Earnings released on 30 Jun 2021

EPS came in at -£0.13, while revenue for the quarter reached £179.00K.

Earnings released on 31 Dec 2020

EPS came in at -£0.03, while revenue for the quarter reached £303.00K.

4BB.L Stock Performance

Access detailed 4BB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
4BB.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
4BB.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More